Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology

Background:

• Coronary no-reflow is a frequent complication during acute percutaneous coronary intervention, especially in acute myocardial infarction and degenerated vein grafts.
• It is linked to a poor prognosis, necessitating prompt identification and management.

Purpose of the Study:

• To elucidate the pathophysiology of coronary no-reflow.
• To identify strategies for preventing and treating this condition during percutaneous coronary interventions.

Main Methods:

• Review of the pathophysiology involving ischemic phase, capillary swelling, endothelial dysfunction, and leukocyte activation.
• Discussion of preventive measures like reduced door-to-balloon time, glycoprotein IIb/IIIa inhibitors, and distal protection devices.
• Evaluation of treatment options including distal intracoronary injections of vasodilators and hemodynamic support.

Main Results:

• Pathophysiology involves capillary edema, endothelial dysfunction, leukocyte adhesion, and distal emboli.
• Preventive strategies aim to minimize ischemia and embolization.
• Intracoronary vasodilators (verapamil, nicardipine, adenosine, nitroprusside) can restore coronary flow in many cases.

Conclusions:

• Coronary no-reflow requires prompt recognition and treatment.
• Multifaceted approaches including prevention and targeted therapies are essential for managing this complication.
• Further research into optimal treatment strategies is warranted.